Mechanisms of enveloped virus entry by membrane fusion

Comprehensive Biophysics

Volumn 5, Issue , 2012, Pages 290-311

  Melikyan, G B ^a   Smith, E C ^b   Dutch, R E ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; LIPID BILAYERS; MERGING; VIRUSES;

CELLULAR RECEPTORS; CONFORMATIONAL CHANGE; CYTOSOLS; ENVELOPED VIRUS; GENETIC MATERIALS; HOST CELLS; LIPID BILAYER MEMBRANES; MEMBRANE FUSION; NUCLEOCAPSIDS; VIRUS ENTRY;

PROTEINS;

EID: 84882741550     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374920-8.00524-5     Document Type: Chapter

References (294)

1. Skehel J.J., Wiley D.C. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell 1998, 95(7):871-874.
2. Weissenhorn W., Dessen A., Calder L.J., Harrison S.C., Skehel J.J., Wiley D.C. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 1999, 16(1):3-9.
3. Chan D.C., Kim P.S. HIV entry and its inhibition. Cell 1998, 93(5):681-684.
4. Lamb R.A., Jardetzky T.S. Structural basis of viral invasion: Lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 2007, 17(4):427-436.
5. Kielian M., Rey F.A. Virus membrane-fusion proteins: More than one way to make a hairpin. Nat. Rev. Microbiol. 2006, 4(1):67-76.
6. Roche S., Albertini A.A., Lepault J., Bressanelli S., Gaudin Y. Structures of vesicular stomatitis virus glycoprotein: Membrane fusion revisited. Cell. Mol. Life Sci. 2008, 65(11):1716-1728.
7. Harrison S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 2008, 15(7):690-698.
8. Backovic M., Jardetzky T.S. Class III viral membrane fusion proteins. Curr. Opin. Struct. Biol. 2009, 19(2):189-196.
9. Chernomordik L.V., Kozlov M.M. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 2008, 15(7):675-683.
10. Melikyan G.B. Common principles and intermediates of viral protein-mediated fusion: The HIV-1 paradigm. Retrovirology 2008, 5(1):111.
11. Blumenthal R., Clague M.J., Durell S.R., Epand R.M. Membrane fusion. Chem. Rev. 2003, 103(1):53-69.
12. White J.M., Delos S.E., Brecher M., Schornberg K. Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 2008, 43(3):189-219.
13. Tamm L.K. Hypothesis: Spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion. Biochim. Biophys. Acta 2003, 1614(1):14-23.
14. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981, 289(5796):366-373.
15. Heldwein E.E., Lou H., Bender F.C., Cohen G.H., Eisenberg R.J., Harrison S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006, 313(5784):217-220.
16. Chen J., Lee K.H., Steinhauer D.A., Stevens D.J., Skehel J.J., Wiley D.C. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 1998, 95:409-417.
17. Bullough P.A., Hughson F.M., Skehel J.J., Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994, 371:37-43.
18. Baker K.A., Dutch R.E., Lamb R.A., Jardetzky T.S. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 1999, 3:309-319.
19. Swanson K., Wen X., Leser G.P., Paterson R.G., Lamb R.A., Jardetzky T.S. Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology 2010, 402(2):372-379.
20. Yin H.S., Paterson R.G., Wen X., Lamb R.A., Jardetzky T.S. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc. Natl. Acad. Sci. USA 2005, 102(26):9288-9293.
21. Buzon V., Natrajan G., Schibli D., Campelo F., Kozlov M.M., Weissenhorn W. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog. 2010, 6(5):e1000880.
22. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89:263-273.
23. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997, 387:426-430.
24. Li L., Lok S.M., Yu I.M., Zhang Y., Kuhn R.J., Chen J., Rossmann M.G. The flavivirus precursor membrane-envelope protein complex: Structure and maturation. Science 2008, 319(5871):1830-1834.
25. Yu I.M., Zhang W., Holdaway H.A., Li L., Kostyuchenko V.A., Chipman P.R., Kuhn R.J., Rossmann M.G., Chen J. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 2008, 319(5871):1834-1837.
26. Modis Y., Ogata S., Clements D., Harrison S.C.A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 2003, 100(12):6986-6991.
27. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427(6972):313-319.
28. Roche S., Bressanelli S., Rey F.A., Gaudin Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 2006, 313(5784):187-191.
29. Roche S., Rey F.A., Gaudin Y., Bressanelli S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 2007, 315(5813):843-848.
30. Kadlec J., Loureiro S., Abrescia N.G., Stuart D.I., Jones I.M. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol. 2008, 15(10):1024-1030.
31. Marsh M., Helenius A. Virus entry: Open sesame. Cell 2006, 124(4):729-740.
32. Smith A.E., Helenius A. How viruses enter animal cells. Science 2004, 304(5668):237-242.
33. Melikyan G.B., Barnard R.J., Markosyan R.M., Young J.A., Cohen F.S. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth. J. Virol. 2004, 78(7):3753-3762.
34. Mothes W., Boerger A.L., Narayan S., Cunningham J.M., Young J.A. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 2000, 103(4):679-689.
35. Doms R.W. Chemokine receptors and HIV entry. AIDS 2001, 15(Suppl 1):S34-S35.
36. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17:657-700.
37. Dolnik O., Kolesnikova L., Becker S. Filoviruses: Interactions with the host cell. Cell. Mol. Life Sci. 2008, 65(5):756-776.
38. Schornberg K., Matsuyama S., Kabsch K., Delos S., Bouton A., White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 2006, 80(8):4174-4178.
39. Chandran K., Sullivan N.J., Felbor U., Whelan S.P., Cunningham J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005, 308(5728):1643-1645.
40. Lamb R.A., Parks G.D. Paramyxoviridae: The viruses and their replication. Fields Virology 2007, Vol. 1:1449-1496. Lippincott Williams & Wilkins, Philadelphia.
41. Smith E.C., Popa A., Chang A., Masante C., Dutch R.E. Viral entry mechanisms: The increasing diversity of paramyxovirus entry. FEBS J. 2009, 276(24):7217-7227.
42. Aguilar H.C., Ataman Z.A., Aspericueta V., Fang A.Q., Stroud M., Negrete O.A., Kammerer R.A., Lee B. A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F). J. Biol. Chem. 2009, 284(3):1628-1635.
43. Bishop K.A., Hickey A.C., Khetawat D., Patch J.R., Bossart K.N., Zhu Z., Wang L.F., Dimitrov D.S., Broder C.C. Residues in the stalk domain of the Hendra virus G glycoprotein modulate conformational changes associated with receptor binding. J. Virol. 2008, 82(22):11398-11409.
44. Deng R., Wang Z., Mirza A.M., Iorio R.M. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 1995, 209:457-469.
45. Lee J.K., Prussia A., Paal T., White L.K., Snyder J.P., Plemper R.K. Functional interaction between paramyxovirus fusion and attachment proteins. J. Biol. Chem. 2008, 283(24):16561-16572.
46. Melanson V.R., Iorio R.M. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J. Virol. 2006, 80(2):623-633.
47. Mirza A.M., Deng R., Iorio R.M. Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidae glycoprotein: Effects on antigenic structure and function. J. Virol. 1994, 68:5093-5099.
48. Porotto M., Murrell M., Greengard O., Moscona A. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: An HN mutation diminishes the rate of F activation and fusion. J. Virol. 2003, 77(6):3647-3654.
49. Sergel T., McGinnes L.W., Peeples M.E., Morrison T.G. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 1993, 193:717-726.
50. Tanabayashi K., Compans R.W. Functional interaction of paramyxovirus glycoproteins: Identification of a domain in Sendai virus HN which promotes cell fusion. J. Virol. 1996, 70:6112-6118.
51. Akhtar J., Shukla D. Viral entry mechanisms: Cellular and viral mediators of herpes simplex virus entry. FEBS J. 2009, 276(24):7228-7236.
52. Heldwein E.E., Krummenacher C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 2008, 65(11):1653-1668.
53. Spear P.G. Herpes simplex virus: Receptors and ligands for cell entry. Cell. Microbiol. 2004, 6(5):401-410.
54. Spear P.G., Eisenberg R.J., Cohen G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 2000, 275(1):1-8.
55. Browne H., Bruun B., Minson T. Plasma membrane requirements for cell fusion induced by herpes simplex virus type 1 glycoproteins gB, gD, gH and gL. J. Gen. Virol. 2001, 82(Pt 6):1419-1422.
56. Bender F.C., Samanta M., Heldwein E.E., de Leon M.P., Bilman E., Lou H., Whitbeck J.C., Eisenberg R.J., Cohen G.H. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J. Virol. 2007, 81(8):3827-3841.
57. Galdiero S., Vitiello M., D'Isanto M., Falanga A., Cantisani M., Browne H., Pedone C., Galdiero M. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules. ChemBioChem 2008, 9(5):758-767.
58. Hannah B.P., Cairns T.M., Bender F.C., Whitbeck J.C., Lou H., Eisenberg R.J., Cohen G.H. Glycoprotein B of herpes simplex virus associates with target membranes via its fusion loops. J. Virol. 2009, 83(13):6825-6836.
59. Lin E., Spear P.G. Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B. Proc. Natl. Acad. Sci. USA 2007, 104(32):13140-13145.
60. Subramanian R.P., Geraghty R.J. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc. Natl. Acad. Sci. USA 2007, 104(8):2903-2908.
61. Armstrong R.T., Kushnir A.S., White J.M. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J. Cell Biol. 2000, 151(2):425-437.
62. Cohen F.S., Melikyan G.B. The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J. Membr. Biol. 2004, 199(1):1-14.
63. Melikyan G.B., Markosyan R.M., Hemmati H., Delmedico M.K., Lambert D.M., Cohen F.S. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol. 2000, 151(2):413-424.
64. Bentz J. Membrane fusion mediated by coiled coils: A hypothesis. Biophys. J. 2000, 78(2):886-900.
65. Kozlov M.M., Chernomordik L.V. A mechanism of protein-mediated fusion: Coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys. J. 1998, 75(3):1384-1396.
66. Lindau M., Almers W. Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion. Curr. Opin. Cell Biol. 1995, 7(4):509-517.
67. Muller M., Katsov K., Schick M. A new mechanism of model membrane fusion determined from Monte Carlo simulation. Biophys. J. 2003, 85(3):1611-1623.
68. Frolov V.A., Dunina-Barkovskaya A.Y., Samsonov A.V., Zimmerberg J. Membrane permeability changes at early stages of influenza hemagglutinin-mediated fusion. Biophys. J. 2003, 85(3):1725-1733.
69. Bonnafous P., Stegmann T. Membrane perturbation and fusion pore formation in influenza hemagglutinin-mediated membrane fusion: A new model for fusion. J. Biol. Chem. 2000, 275(9):6160-6166.
70. Bartosch B., Cosset F.L. Cell entry of hepatitis C virus. Virology 2006, 348(1):1-12.
71. Helle F., Dubuisson J. Hepatitis C virus entry into host cells. Cell. Mol. Life Sci. 2008, 65(1):100-112.
72. von Hahn T., Rice C.M. Hepatitis C virus entry. J. Biol. Chem. 2008, 283:3689-3693.
73. Lamb R.A., Paterson R.G., Jardetzky T.S. Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures. Virology 2006, 344(1):30-37.
74. Lee K.K. Architecture of a nascent viral fusion pore. EMBO J. 2010, 29(7):1299-1311.
75. Melikyan G.B., Niles W.D., Cohen F.S. The fusion kinetics of influenza hemagglutinin expressing cells to planar bilayer membranes is affected by HA density and host cell surface. J. Gen. Physiol. 1995, 106:783-802.
76. Floyd D.L., Ragains J.R., Skehel J.J., Harrison S.C., van Oijen A.M. Single-particle kinetics of influenza virus membrane fusion. Proc. Natl. Acad. Sci. USA 2008, 105(40):15382-15387.
77. Wessels L., Elting M.W., Scimeca D., Weninger K. Rapid membrane fusion of individual virus particles with supported lipid bilayers. Biophys. J. 2007, 93(2):526-538.
78. White J., Kartenbeck J., Helenius A. Membrane fusion activity of influenza virus. EMBO J. 1982, 1(2):217-222.
79. Wilschut J., Scholma J., Stegmann T. Molecular mechanisms of membrane fusion and applications of membrane fusion techniques. Adv. Exp. Med. Biol. 1988, 238:105-126.
80. Kielian M.C., Keranen S., Kaariainen L., Helenius A. Membrane fusion mutants of Semliki Forest virus. J. Cell Biol. 1984, 98(1):139-145.
81. Blumenthal R., Gallo S.A., Viard M., Raviv Y., Puri A. Fluorescent lipid probes in the study of viral membrane fusion. Chem. Phys. Lipids 2002, 116(1-2):39-55.
82. Stegmann T., Schoen P., Bron R., Wey J., Bartoldus I., Ortiz A., Nieva J.L., Wilschut J. Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay. Biochemistry 1993, 32(42):11330-11337.
83. Roche S., Gaudin Y. Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion. J. Virol. 2004, 78(16):8746-8752.
84. Hoekstra D. Fluorescence assays to monitor membrane fusion: Potential application in biliary lipid secretion and vesicle interactions. Hepatology 1990, 12(3 Pt 2):61S-66S.
85. Kondo N., Miyauchi K., Meng F., Iwamoto A., Matsuda Z. Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 2010, 285(19):14681-14688.
86. Wang J., Kondo N., Long Y., Iwamoto A., Matsuda Z. Monitoring of HIV-1 envelope-mediated membrane fusion using modified split green fluorescent proteins. J. Virol. Methods 2009, 161(2):216-222.
87. Holland A.U., Munk C., Lucero G.R., Nguyen L.D., Landau N.R. Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. Virology 2004, 319(2):343-352.
88. Huerta L., Lopez-Balderas N., Rivera-Toledo E., Sandoval G., Gomez-Icazbalceta G., Villarreal C., Lamoyi E., Larralde C. HIV-envelope-dependent cell-cell fusion: Quantitative studies. ScientificWorldJournal 2009, 9:746-763.
89. Zimmerberg J., Blumenthal R., Sarkar D.P., Curran M., Morris S.J. Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J. Cell Biol. 1994, 127(6 Pt 2):1885-1894.
90. Lineberger J.E., Danzeisen R., Hazuda D.J., Simon A.J., Miller M.D. Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion. J. Virol. 2002, 76(7):3522-3533.
91. Chernomordik L.V., Frolov V.A., Leikina E., Bronk P., Zimmerberg J. The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation. J. Cell Biol. 1998, 140(6):1369-1382.
92. Dey B., Berger E.A. Vaccinia-based reporter gene cell-fusion assays to quantitate functional interactions of HIV envelope glycoprotein with receptors. Curr. Protoc. Immunol. 2003, Chapter 12, Unit 12.10.
93. Rucker J., Doranz B.J., Edinger A.L., Long D., Berson J.F., Doms R.W. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry. Methods Enzymol. 1997, 288:118-133.
94. Sakamoto T., Ushijima H., Okitsu S., Suzuki E., Sakai K., Morikawa S., Muller W.E. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene. J. Virol. Methods 2003, 114(2):159-166.
95. Kobayashi M., Bennett M.C., Bercot T., Singh I.R. Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay. J. Virol. 2006, 80(4):1817-1825.
96. Fortin J.F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 1997, 71(5):3588-3596.
97. Janas A.M., Wu L. HIV-1 interactions with cells: From viral binding to cell-cell transmission. Curr. Protoc. Cell Biol. 2009, Chapter 26, Unit 26.5.
98. Daecke J., Fackler O.T., Dittmar M.T., Krausslich H.G. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J. Virol. 2005, 79(3):1581-1594.
99. Tobiume M., Lineberger J.E., Lundquist C.A., Miller M.D., Aiken C. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J. Virol. 2003, 77(19):10645-10650.
100. Thomas J.A., Ott D.E., Gorelick R.J. Efficiency of human immunodeficiency virus type 1 postentry infection processes: Evidence against disproportionate numbers of defective virions. J. Virol. 2007, 81(8):4367-4370.
101. Cavrois M., De Noronha C., Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 2002, 20(11):1151-1154.
102. Kolokoltsov A.A., Davey R.A. Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay. J. Virol. 2004, 78(10):5124-5132.
103. Saeed M.F., Kolokoltsov A.A., Davey R.A. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. J. Virol. Methods 2006, 135(2):143-150.
104. Miyauchi K., Kim Y., Latinovic O., Morozov V., Melikyan G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137(3):433-444.
105. Miyauchi K., Kozlov M.M., Melikyan G.B. Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation. PLoS Pathog. 2009, 5(9):e1000585.
106. Arhel N., Genovesio A., Kim K.A., Miko S., Perret E., Olivo-Marin J.C., Shorte S., Charneau P. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat. Methods 2006, 3(10):817-824.
107. Brandenburg B., Lee L.Y., Lakadamyali M., Rust M.J., Zhuang X., Hogle J.M. Imaging poliovirus entry in live cells. PLoS Biol. 2007, 5(7):e183.
108. Brauchle C., Seisenberger G., Endress T., Ried M.U., Buning H., Hallek M. Single virus tracing: Visualization of the infection pathway of a virus into a living cell. ChemPhysChem 2002, 3(3):299-303.
109. Lakadamyali M., Rust M.J., Babcock H.P., Zhuang X. Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. USA 2003, 100(16):9280-9285.
110. Le Blanc I., Luyet P.P., Pons V., Ferguson C., Emans N., Petiot A., Mayran N., Demaurex N., Faure J., Sadoul R., Parton R.G., Gruenberg J. Endosome-to-cytosol transport of viral nucleocapsids. Nat. Cell Biol. 2005, 7(7):653-664.
111. Joo K.I., Wang P. Visualization of targeted transduction by engineered lentiviral vectors. Gene Ther. 2008, 15(20):1384-1396.
112. van der Schaar H.M., Rust M.J., Waarts B.L., van der Ende-Metselaar H., Kuhn R.J., Wilschut J., Zhuang X., Smit J.M. Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J. Virol. 2007, 81(21):12019-12028.
113. Lowy R.J., Sarkar D.P., Chen Y., Blumenthal R. Observation of single influenza virus-cell fusion and measurement by fluorescence video microscopy. Proc. Natl. Acad. Sci. USA 1990, 87(5):1850-1854.
114. Markosyan R.M., Cohen F.S., Melikyan G.B. Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane. Mol. Biol. Cell 2005, 16(12):5502-5513.
115. Melikyan G.B., Barnard R.J., Abrahamyan L.G., Mothes W., Young J.A. Imaging individual retroviral fusion events: From hemifusion to pore formation and growth. Proc. Natl. Acad. Sci. USA 2005, 102(24):8728-8733.
116. Kozlov M.M., Leikin S.L., Chernomordik L.V., Markin V.S., Chizmadzhev Y.A. Stalk mechanism of vesicle fusion: Intermixing of aqueous contents. Eur. Biophys. J. 1989, 17(3):121-129.
117. Kozlovsky Y., Chernomordik L.V., Kozlov M.M. Lipid intermediates in membrane fusion: Formation, structure, and decay of hemifusion diaphragm. Biophys. J. 2002, 83(5):2634-2651.
118. Chernomordik L.V., Melikyan G.B., Chizmadzhev Y.A. Biomembrane fusion: A new concept derived from model studies using two interacting planar lipid bilayers. Biochim. Biophys. Acta 1987, 906(3):309-352.
119. Melikyan G.B., White J.M., Cohen F.S. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 1995, 131(3):679-691.
120. Kasson P.M., Zomorodian A., Park S., Singhal N., Guibas L.J., Pande V.S. Persistent voids: A new structural metric for membrane fusion. Bioinformatics 2007, 23(14):1753-1759.
121. Katsov K., Muller M., Schick M. Field theoretic study of bilayer membrane fusion: I. Hemifusion mechanism. Biophys. J. 2004, 87(5):3277-3290.
122. Lee J.Y., Schick M. Calculation of free energy barriers to the fusion of small vesicles. Biophys. J. 2008, 94(5):1699-1706.
123. Chernomordik L.V., Kozlov M.M. Protein-lipid interplay in fusion and fission of biological membranes. Annu. Rev. Biochem. 2003, 72:175-207.
124. Cohen F.S., Markosyan R.M., Melikyan G.B. The process of membrane fusion: Nipples, hemifusion, pores, and pore growth. Curr. Top. Membr. 2002, 52:501-529.
125. Kuzmin P.I., Zimmerberg J., Chizmadzhev Y.A., Cohen F.S. A quantitative model for membrane fusion based on low-energy intermediates. Proc. Natl. Acad. Sci. USA 2001, 98(13):7235-7240.
126. Markin V.S., Albanesi J.P. Membrane fusion: Stalk model revisited. Biophys. J. 2002, 82(2):693-712.
127. Chernomordik L., Kozlov M.M., Zimmerberg J. Lipids in biological membrane fusion. J. Membr. Biol. 1995, 146(1):1-14.
128. Chernomordik L.V., Leikina E.A., Zimmerberg J. Lysolipid inhibition of low pH-triggered viral fusion. Biophys. J. 1994, 66(2):A6.
129. Helfrich W. Elastic properties of lipid bilayers: Theory and possible experiments. Z. Naturforsch. 1973, 28c:693-703.
130. Markin V.S., Kozlov M.M., Borovjagin V.L. On the theory of membrane fusion: The stalk mechanism. Gen. Physiol. Biophys. 1984, 3(5):361-377.
131. Melikyan G.B., Brener S.A., Ok D.C., Cohen F.S. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J. Cell Biol. 1997, 136:995-1005.
132. Chernomordik L.V., Kozlov M.M. Membrane hemifusion: Crossing a chasm in two leaps. Cell 2005, 123(3):375-382.
133. Dimitrov A.S., Xiao X., Dimitrov D.S., Blumenthal R. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes. J. Biol. Chem. 2001, 276(32):30335-30341.
134. Koschinski A., Wengler G., Wengler G., Repp H. The membrane proteins of flaviviruses form ion-permeable pores in the target membrane after fusion: Identification of the pores and analysis of their possible role in virus infection. J. Gen. Virol. 2003, 84(Pt 7):1711-1721.
135. Qiao H., Armstrong R.T., Melikyan G.B., Cohen F.S., White J.M. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol. Biol. Cell 1999, 10(8):2759-2769.
136. Melikyan G.B., Lin S., Roth M.G., Cohen F.S. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol. Biol. Cell 1999, 10(6):1821-1836.
137. Koschinski A., Wengler G., Wengler G., Repp H. Rare earth ions block the ion pores generated by the class II fusion proteins of alphaviruses and allow analysis of the biological functions of these pores. J. Gen. Virol. 2005, 86(Pt 12):3311-3320.
138. Günther-Ausborn S., Praetor A., Stegmann T. Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine. J. Biol. Chem. 1995, 270(49):29279-29285.
139. Markosyan R.M., Bates P., Cohen F.S., Melikyan G.B. A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. Biophys. J. 2004, 87(5):3291-3298.
140. Melikyan G.B., Egelhofer M., von Laer D. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion. J. Virol. 2006, 80(7):3249-3258.
141. Gaudin Y. Rabies virus-induced membrane fusion pathway. J. Cell Biol. 2000, 150(3):601-612.
142. Zaitseva E., Mittal A., Griffin D.E., Chernomordik L.V. Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. J. Cell Biol. 2005, 169(1):167-177.
143. Blumenthal R., Schoch C., Puri A., Clague M.J. A dissection of steps leading to viral envelope protein-mediated membrane fusion. Ann. N. Y. Acad. Sci. 1991, 635:285-296.
144. Schoch C., Blumenthal R., Clague M.J. A long-lived state for influenza virus-erythrocyte complexes committed to fusion at neutral pH. FEBS Lett. 1992, 311(3):221-225.
145. Leikina E., Chernomordik L.V. Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion. Mol. Biol. Cell 2000, 11(7):2359-2371.
146. Markosyan R.M., Cohen F.S., Melikyan G.B. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol. Biol. Cell 2003, 14(3):926-938.
147. Vogel S.S., Leikina E.A., Chernomordik L.V. Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger. J. Biol. Chem. 1993, 268(34):25764-25768.
148. Doms R.W., Helenius A., White J. Membrane fusion activity of the influenza virus hemagglutinin: The low pH-induced conformational change. J. Biol. Chem. 1985, 260(5):2973-2981.
149. Markovic I., Pulyaeva H., Sokoloff A., Chernomordik L.V. Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 TRIMERS into multiprotein aggregates. J. Cell Biol. 1998, 143(5):1155-1166.
150. Melikyan G.B., Markosyan R.M., Roth M.G., Cohen F.S. A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol. Biol. Cell 2000, 11(11):3765-3775.
151. White J.M., Wilson I.A. Anti-peptide antibodies detect steps in a protein conformational change: Low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 1987, 105(6 Pt 2):2887-2896.
152. Stegmann T., White J.M., Helenius A. Intermediates in influenza induced membrane fusion. EMBO J. 1990, 9(13):4231-4241.
153. Dimitrov A.S., Louis J.M., Bewley C.A., Clore G.M., Blumenthal R. Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry 2005, 44(37):12471-12479.
154. Finnegan C.M., Berg W., Lewis G.K., DeVico A.L. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion. J. Virol. 2001, 75(22):11096-11105.
155. Finnegan C.M., Berg W., Lewis G.K., DeVico A.L. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion. J. Virol. 2002, 76(23):12123-12134.
156. Haim H., Steiner I., Panet A. Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures. J. Virol. 2007, 81(7):3525-3534.
157. Moore J.P., Sattentau Q.J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 1994, 68(1):469-484.
158. Sattentau Q.J., Moore J.P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 1991, 174(2):407-415.
159. Salzwedel K., Smith E.D., Dey B., Berger E.A. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: Soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. J. Virol. 2000, 74(1):326-333.
160. Gorny M.K., Gianakakos V., Sharpe S., Zolla-Pazner S. Generation of human monoclonal antibodies to human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1989, 86(5):1624-1628.
161. Gustchina E., Louis J.M., Lam S.N., Bewley C.A., Clore G.M. A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains. J. Virol. 2007, 81(23):12946-12953.
162. Miller M.D., Geleziunas R., Bianchi E., Lennard S., Hrin R., Zhang H., Lu M., An Z., Ingallinella P., Finotto M., Mattu M., Finnefrock A.C., Bramhill D., Cook J., Eckert D.M., Hampton R., Patel M., Jarantow S., Joyce J., Ciliberto G., Cortese R., Lu P., Strohl W., Schleif W., McElhaugh M., Lane S., Lloyd C., Lowe D., Osbourn J., Vaughan T., Emini E., Barbato G., Kim P.S., Hazuda D.J., Shiver J.W., Pessi A. A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. Proc. Natl. Acad. Sci. USA 2005, 102(41):14759-14764.
163. Nelson J.D., Kinkead H., Brunel F.M., Leaman D., Jensen R., Louis J.M., Maruyama T., Bewley C.A., Bowdish K., Clore G.M., Dawson P.E., Frederickson S., Mage R.G., Richman D.D., Burton D.R., Zwick M.B. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology 2008, 377(1):170-183.
164. Montero M., van Houten N.E., Wang X., Scott J.K. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 2008, 72(1):54-84.
165. Burton D.R., Stanfield R.L., Wilson I.A. Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. USA 2005, 102(42):14943-14948.
166. de Rosny E., Vassell R., Jiang S., Kunert R., Weiss C.D. Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: Implications for fusion-inducing conformational changes. J. Virol. 2004, 78(5):2627-2631.
167. Gallo S.A., Puri A., Blumenthal R. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry 2001, 40(41):12231-12236.
168. Mkrtchyan S.R., Markosyan R.M., Eadon M.T., Moore J.P., Melikyan G.B., Cohen F.S. Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion. J. Virol. 2005, 79(17):11161-11169.
169. Liao M., Kielian M. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J. Cell Biol. 2005, 171(1):111-120.
170. Hrobowski Y.M., Garry R.F., Michael S.F. Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol. J. 2005, 2:49.
171. Schmidt A.G., Yang P.L., Harrison S.C. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog. 2010, 6(4):e1000851.
172. Eckert D.M., Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 2001, 70:777-810.
173. Netter R.C., Amberg S.M., Balliet J.W., Biscone M.J., Vermeulen A., Earp L.J., White J.M., Bates P. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. J. Virol. 2004, 78(24):13430-13439.
174. Russell C.J., Jardetzky T.S., Lamb R.A. Membrane fusion machines of paramyxoviruses: Capture of intermediates of fusion. EMBO J. 2001, 20(15):4024-4034.
175. Gallo S.A., Reeves J.D., Garg H., Foley B., Doms R.W., Blumenthal R. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion. Retrovirology 2006, 3:90.
176. Galdiero S., Vitiello M., D'Isanto M., Falanga A., Collins C., Raieta K., Pedone C., Browne H., Galdiero M. Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. J. Gen. Virol. 2006, 87(Pt 5):1085-1097.
177. Gaudin Y., Ruigrok R.W., Knossow M., Flamand A. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J. Virol. 1993, 67(3):1365-1372.
178. Puri A., Winick J., Lowy R.J., Covell D., Eidelman O., Walter A., Blumenthal R. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J. Biol. Chem. 1988, 263(10):4749-4753.
179. Blumenthal R., Bali-Puri A., Walter A., Covell D., Eidelman O. pH-dependent fusion of vesicular stomatitis virus with Vero cells: Measurement by dequenching of octadecyl rhodamine fluorescence. J. Biol. Chem. 1987, 262(28):13614-13619.
180. Waarts B.L., Smit J.M., Aneke O.J., McInerney G.M., Liljestrom P., Bittman R., Wilschut J. Reversible acid-induced inactivation of the membrane fusion protein of Semliki Forest virus. J. Virol. 2005, 79(12):7942-7948.
181. Tatulian S.A., Tamm L.K. Reversible pH-dependent conformational change of reconstituted influenza hemagglutinin. J. Mol. Biol. 1996, 260(3):312-316.
182. Leikina E., Ramos C., Markovic I., Zimmerberg J., Chernomordik L.V. Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin. EMBO J. 2002, 21(21):5701-5710.
183. Stiasny K., Allison S.L., Marchler-Bauer A., Kunz C., Heinz F.X. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 1996, 70(11):8142-8147.
184. Wahlberg J.M., Boere W.A., Garoff H. The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J. Virol. 1989, 63(12):4991-4997.
185. Pak C.C., Puri A., Blumenthal R. Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [125I]iodonaphthyl azide photolabeling studies in biological membranes. Biochemistry 1997, 36(29):8890-8896.
186. Gibbons D.L., Erk I., Reilly B., Navaza J., Kielian M., Rey F.A., Lepault J. Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell 2003, 114(5):573-583.
187. Ruigrok R.W., Aitken A., Calder L.J., Martin S.R., Skehel J.J., Wharton S.A., Weis W., Wiley D.C. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J. Gen. Virol. 1988, 69(Pt 11):2785-2795.
188. Damico R.L., Crane J., Bates P. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA 1998, 95(5):2580-2585.
189. Delos S.E., Godby J.A., White J.M. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: Implications for fusion activation. J. Virol. 2005, 79(6):3488-3499.
190. Furuta R.A., Wild C.T., Weng Y., Weiss C.D. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 1998, 5(4):276-279.
191. Koshiba T., Chan D.C. The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions. J. Biol. Chem. 2002, 278:7573-7579.
192. Kilgore N.R., Salzwedel K., Reddick M., Allaway G.P., Wild C.T. Direct evidence that C-peptide inhibitors of human immunodeficiency virus type 1 entry bind to the gp41 N-helical domain in receptor-activated viral envelope. J. Virol. 2003, 77(13):7669-7672.
193. +-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem. 1996, 271(23):13417-13421.
194. Durrer P., Gaudin Y., Ruigrok R.W., Graf R., Brunner J. Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses. J. Biol. Chem. 1995, 270(29):17575-17581.
195. Stegmann T., Delfino J.M., Richards F.M., Helenius A. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J. Biol. Chem. 1991, 266(27):18404-18410.
196. Egelhofer M., Brandenburg G., Martinius H., Schult-Dietrich P., Melikyan G., Kunert R., Baum C., Choi I., Alexandrov A., von Laer D. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J. Virol. 2004, 78(2):568-575.
197. Barnard R.J., Narayan S., Dornadula G., Miller M.D., Young J.A. Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating. J. Virol. 2004, 78(19):10433-10441.
198. Chen J., Skehel J.J., Wiley D.C. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 1999, 96(16):8967-8972.
199. Park H.E., Gruenke J.A., White J.M. Leash in the groove mechanism of membrane fusion. Nat. Struct. Biol. 2003, 10(12):1048-1053.
200. Borrego-Diaz E., Peeples M.E., Markosyan R.M., Melikyan G.B., Cohen F.S. Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. Virology 2003, 316(2):234-244.
201. Vishwanathan S.A., Hunter E. Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. J. Virol. 2008, 82(11):5118-5126.
202. Salzwedel K., West J.T., Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 1999, 73(3):2469-2480.
203. Munoz-Barroso I., Salzwedel K., Hunter E., Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 1999, 73(7):6089-6092.
204. Bellamy-McIntyre A.K., Lay C.S., Baar S., Maerz A.L., Talbo G.H., Drummer H.E., Poumbourios P. Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion. J. Biol. Chem. 2007, 282(32):23104-23116.
205. Noah E., Biron Z., Naider F., Arshava B., Anglister J. The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide. Biochemistry 2008, 47(26):6782-6792.
206. Delos S.E., La B., Gilmartin A., White J.M. Studies of the 'chain reversal regions' of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: Analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry. J. Virol. 2010, 84(11):5687-5694.
207. Maerz A.L., Center R.J., Kemp B.E., Kobe B., Poumbourios P. Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J. Virol. 2000, 74(14):6614-6621.
208. Jeetendra E., Ghosh K., Odell D., Li J., Ghosh H.P., Whitt M.A. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J. Virol. 2003, 77(23):12807-12818.
209. Liao M., Kielian M. Functions of the stem region of the Semliki Forest virus fusion protein during virus fusion and assembly. J. Virol. 2006, 80(22):11362-11369.
210. Kemble G.W., Danieli T., White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 1994, 76(2):383-391.
211. Tong S., Compans R.W. Oligomerization, secretion, and biological function of an anchor-free parainfluenza virus type 2 (PI2) fusion protein. Virology 2000, 270(2):368-376.
212. Frolov V., Cho M., Reese T.S., Zimmerberg J. Both hemifusion and fusion pores are induced by GPI-linked influenza hemagglutinin. Traffic 2000, 1:622-630.
213. Nüssler F., Clague M.J., Herrmann A. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin. Biophys. J. 1997, 73(5):2280-2291.
214. Weiss C.D., White J.M. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 1993, 67(12):7060-7066.
215. West J.T., Johnston P.B., Dubay S.R., Hunter E. Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity. J. Virol. 2001, 75(20):9601-9612.
216. Cleverley D.Z., Lenard J. The transmembrane domain in viral fusion: Essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. USA 1998, 95(7):3425-3430.
217. Miyauchi K., Komano J., Yokomaku Y., Sugiura W., Yamamoto N., Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 2005, 79(8):4720-4729.
218. Shang L., Yue L., Hunter E. Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J. Virol. 2008, 82(11):5417-5428.
219. Bissonnette M.L., Donald J.E., DeGrado W.F., Jardetzky T.S., Lamb R.A. Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J. Mol. Biol. 2009, 386(1):14-36.
220. Yin H.S., Wen X., Paterson R.G., Lamb R.A., Jardetzky T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006, 439(7072):38-44.
221. Waning D.L., Russell C.J., Jardetzky T.S., Lamb R.A. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc. Natl. Acad. Sci. USA 2004, 101(25):9217-9222.
222. Chowdary T.K., Heldwein E.E. Syncytial phenotype of C-terminally truncated herpes simplex virus type 1 gB is associated with diminished membrane interactions. J. Virol. 2010, 84(10):4923-4935.
223. Cote M., Zheng Y.M., Albritton L.M., Liu S.L. Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations. J. Virol. 2008, 82(5):2543-2554.
224. Kozerski C., Ponimaskin E., Schroth-Diez B., Schmidt M.F., Herrmann A. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore. J. Virol. 2000, 74(16):7529-7537.
225. Freed E.O., Martin M.A. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 1995, 270(41):23883-23886.
226. Abrahamyan L.G., Mkrtchyan S.R., Binley J., Lu M., Melikyan G.B., Cohen F.S. The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle. J. Virol. 2005, 79(1):106-115.
227. Edwards T.G., Wyss S., Reeves J.D., Zolla-Pazner S., Hoxie J.A., Doms R.W., Baribaud F. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J. Virol. 2002, 76(6):2683-2691.
228. Dubay J.W., Roberts S.J., Hahn B.H., Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 1992, 66(11):6616-6625.
229. Loving R., Li K., Wallin M., Sjoberg M., Garoff H. R-peptide cleavage potentiates fusion-controlling isomerization of the intersubunit disulfide in Moloney murine leukemia virus Env. J. Virol. 2008, 82(5):2594-2597.
230. Jiang J., Aiken C. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J. Virol. 2007, 81(18):9999-10008.
231. Taylor B.M., Foulke J.S., Flinko R., Heredia A., DeVico A., Reitz M. An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence. J. Virol. 2008, 82(11):5460-5471.
232. Spies C.P., Compans R.W. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 1994, 203(1):8-19.
233. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: A novel role of the gp41 cytoplasmic tail. J. Virol. 2004, 78(7):3429-3435.
234. Wyss S., Dimitrov A.S., Baribaud F., Edwards T.G., Blumenthal R., Hoxie J.A. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J. Virol. 2005, 79(19):12231-12241.
235. Bobkova M., Stitz J., Engelstadter M., Cichutek K., Buchholz C.J. Identification of R-peptides in envelope proteins of C-type retroviruses. J. Gen. Virol. 2002, 83(Pt 9):2241-2246.
236. Green N., Shinnick T.M., Witte O., Ponticelli A., Sutcliffe J.G., Lerner R.A. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 1981, 78(10):6023-6027.
237. Melikyan G.B., Markosyan R.M., Brener S.A., Rozenberg Y., Cohen F.S. Role of the cytoplasmic tail of ecotropic Moloney murine leukemia virus Env protein in fusion pore formation. J. Virol. 2000, 74(1):447-455.
238. Chernomordik L., Chanturiya A.N., Suss-Toby E., Nora E., Zimmerberg J. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 1994, 68(11):7115-7123.
239. Viard M., Ablan S.D., Zhou M., Veenstra T.D., Freed E.O., Raviv Y., Blumenthal R. Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry 2008, 47(7):1977-1983.
240. Lu L., Zhu Y., Huang J., Chen X., Yang H., Jiang S., Chen Y.H. Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: Interaction with gp41 fusion core. J. Biol. Chem. 2008, 283(24):16723-16731.
241. Carr C.M., Chaudhry C., Kim P.S. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc. Natl. Acad. Sci. USA 1997, 94(26):14306-14313.
242. Markosyan R.M., Cohen F.S., Melikyan G.B. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol. Biol. Cell 2000, 11(4):1143-1152.
243. Blumenthal R., Sarkar D.P., Durell S., Howard D.E., Morris S.J. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J. Cell Biol. 1996, 135(1):63-71.
244. Danieli T., Pelletier S.L., Henis Y.I., White J.M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 1996, 133(3):559-569.
245. Gunther-Ausborn S., Schoen P., Bartoldus I., Wilschut J., Stegmann T. Role of hemagglutinin surface density in the initial stages of influenza virus fusion: Lack of evidence for cooperativity. J. Virol. 2000, 74(6):2714-2720.
246. Bentz J. Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion. Biophys. J. 2000, 78(1):227-245.
247. Roche S., Gaudin Y. Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 2002, 297(1):128-135.
248. Klasse P.J. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. Virology 2007, 369(2):245-262.
249. Magnus C., Rusert P., Bonhoeffer S., Trkola A., Regoes R.R. Estimating the stoichiometry of HIV entry. J. Virol. 2009, 83:1523-1531.
250. Yang X., Kurteva S., Ren X., Lee S., Sodroski J. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J. Virol. 2005, 79(19):12132-12147.
251. Markovic I., Leikina E., Zhukovsky M., Zimmerberg J., Chernomordik L.V. Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J. Cell Biol. 2001, 155(5):833-844.
252. Leikina E., Mittal A., Cho M.S., Melikov K., Kozlov M.M., Chernomordik L.V. Influenza hemagglutinins outside of the contact zone are necessary for fusion pore expansion. J. Biol. Chem. 2004, 279(25):26526-26532.
253. Tse F.W., Iwata A., Almers W. Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J. Cell Biol. 1993, 121(3):543-552.
254. Zhang W., Chipman P.R., Corver J., Johnson P.R., Zhang Y., MGBRhopadhyay S., Baker T.S., Strauss J.H., Rossmann M.G., Kuhn R.J. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 2003, 10(11):907-912.
255. Ruigrok R.W., Andree P.J., Hooft van Huysduynen R.A., Mellema J.E. Characterization of three highly purified influenza virus strains by electron microscopy. J. Gen. Virol. 1984, 65(Pt 4):799-802.
256. Zhu P., Chertova E., Bess J., Lifson J.D., Arthur L.O., Liu J., Taylor K.A., Roux K.H. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA 2003, 100(26):15812-15817.
257. Murphy R.F., Powers S., Cantor C.R. Endosome pH measured in single cells by dual fluorescence flow cytometry: Rapid acidification of insulin to pH 6. J. Cell Biol. 1984, 98(5):1757-1762.
258. Yamashiro D.J., Maxfield F.R. Kinetics of endosome acidification in mutant and wild-type Chinese hamster ovary cells. J. Cell Biol. 1987, 105(6 Pt 1):2713-2721.
259. Altan N., Chen Y., Schindler M., Simon S.M. Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc. Natl. Acad. Sci. USA 1999, 96(8):4432-4437.
260. Horvath C.M., Paterson R.G., Shaughnessy M.A., Wood R., Lamb R.A. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia. J. Virol. 1992, 66:4564-4569.
261. Maddon P.J., McDougal J.S., Clapham P.R., Dalgleish A.G., Jamal S., Weiss R.A., Axel R.HIV infection does not require endocytosis of its receptor, CD4. Cell 1988, 54(6):865-874.
262. McClure M.O., Marsh M., Weiss R.A. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J. 1988, 7(2):513-518.
263. Ashorn P.A., Berger E.A., Moss B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 1990, 64(5):2149-2156.
264. Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., Engleman E.G. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 1987, 49(5):659-668.
265. Fredericksen B.L., Wei B.L., Yao J., Luo T., Garcia J.V. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol. 2002, 76(22):11440-11446.
266. Schaeffer E., Soros V.B., Greene W.C. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J. Virol. 2004, 78(3):1375-1383.
267. Kolokoltsov A.A., Deniger D., Fleming E.H., Roberts N.J., Karpilow J.M., Davey R.A. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J. Virol. 2007, 81(14):7786-7800.
268. Beer C., Andersen D.S., Rojek A., Pedersen L. Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J. Virol. 2005, 79(16):10776-10787.
269. Katen L.J., Januszeski M.M., Anderson W.F., Hasenkrug K.J., Evans L.H. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J. Virol. 2001, 75(11):5018-5026.
270. Pontow S.E., Heyden N.V., Wei S., Ratner L. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion. J. Virol. 2004, 78(13):7138-7147.
271. Nicoziani P., Vilhardt F., Llorente A., Hilout L., Courtoy P.J., Sandvig K., van Deurs B. Role for dynamin in late endosome dynamics and trafficking of the cation-independent mannose 6-phosphate receptor. Mol. Biol. Cell 2000, 11(2):481-495.
272. Praefcke G.J., McMahon H.T. The dynamin superfamily: Universal membrane tubulation and fission molecules?. Nat. Rev. Mol. Cell Biol. 2004, 5(2):133-147.
273. Johannsdottir H.K., Mancini R., Kartenbeck J., Amato L., Helenius A. Host cell factors and functions involved in vesicular stomatitis virus entry. J. Virol. 2009, 83:440-453.
274. Falguieres T., Luyet P.P., Gruenberg J. Molecular assemblies and membrane domains in multivesicular endosome dynamics. Exp. Cell Res. 2009, 315(9):1567-1573.
275. Krishnan M.N., Ng A., SGBRumaran B., Gilfoy F.D., Uchil P.D., Sultana H., Brass A.L., Adametz R., Tsui M., Qian F., Montgomery R.R., Lev S., Mason P.W., Koski R.A., Elledge S.J., Xavier R.J., Agaisse H., Fikrig E. RNA interference screen for human genes associated with West Nile virus infection. Nature 2008, 455(7210):242-245.
276. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926.
277. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., Espeseth A.S. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4(5):495-504.
278. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135(1):49-60.
279. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., Becker D., Khalil H., Ogilvie L.A., Hess S., Maurer A.P., Muller E., Wolff T., Rudel T., Meyer T.F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463(7282):818-822.
280. Epand R.M., Epand R.F. Thermal denaturation of influenza virus and its relationship to membrane fusion. Biochem. J. 2002, 365(Pt 3):841-848.
281. Remeta D.P., Krumbiegel M., Minetti C.A., Puri A., Ginsburg A., Blumenthal R. Acid-induced changes in thermal stability and fusion activity of influenza hemagglutinin. Biochemistry 2002, 41(6):2044-2054.
282. Kim C.H., Macosko J.C., Shin Y.K. The mechanism for low-pH-induced clustering of phospholipid vesicles carrying the HA2 ectodomain of influenza hemagglutinin. Biochemistry 1998, 37(1):137-144.
283. LeDuc D.L., Shin Y.K., Epand R.F., Epand R.M. Factors determining vesicular lipid mixing induced by shortened constructs of influenza hemagglutinin. Biochemistry 2000, 39(10):2733-2739.
284. Leikina E., LeDuc D.L., Macosko J.C., Epand R., Epand R., Shin Y.K., Chernomordik L.V. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion. Biochemistry 2001, 40(28):8378-8386.
285. Clancy E.K., Duncan R. Reovirus FAST protein transmembrane domains function in a modular, primary sequence-independent manner to mediate cell-cell membrane fusion. J. Virol. 2009, 83(7):2941-2950.
286. Corcoran J.A., Syvitski R., Top D., Epand R.M., Epand R.F., Jakeman D., Duncan R. Myristoylation, a protruding loop, and structural plasticity are essential features of a nonenveloped virus fusion peptide motif. J. Biol. Chem. 2004, 279(49):51386-51394.
287. Shmulevitz M., Duncan R. A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses. EMBO J. 2000, 19(5):902-912.
288. Yu Y.G., King D.S., Shin Y.K. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 1994, 266(5183):274-276.
289. Li Y., Han X., Tamm L.K. Thermodynamics of fusion peptide-membrane interactions. Biochemistry 2003, 42(23):7245-7251.
290. Qiang W., Sun Y., Weliky D.P. A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide. Proc. Natl. Acad. Sci. USA 2009, 106(36):15314-15319.
291. Han X., Bushweller J.H., Cafiso D.S., Tamm L.K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 2001, 8(8):715-720.
292. Haque M.E., Koppaka V., Axelsen P.H., Lentz B.R. Properties and structures of the influenza and HIV fusion peptides on lipid membranes: Implications for a role in fusion. Biophys. J. 2005, 89(5):3183-3194.
293. Rapaport D., Shai Y. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes. J. Biol. Chem. 1994, 269(21):15124-15131.
294. Kerppola T.K. Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell Biol. 2006, 7(6):449-456.